Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth

Cancer Science

Volumn 99, Issue 8, 2008, Pages 1626-1632

  Hosokawa, Masayo ^a,b   Kashiwaya, Kotoe ^a,b   Eguchi, Hidetoshi ^c   Ohigashi, Hiroaki ^c   Ishikawa, Osamu ^c   Furihata, Mutsuo ^d   Shinomura, Yasuhisa ^b   Imai, Kohzoh ^b   Nakamura, Yusuke ^a   Nakagawa, Hidewaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CYSTATIN 6 PROTEIN; CYSTEINE PROTEINASE INHIBITOR; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PANCREAS CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTATINS; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 49749117101     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00869.x     Document Type: Article

References (25)

1. Di M, Agno EP, Reber HA, Tempero MA. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 1999; 117: 1464-84.
2. Wray CJ, Ahmad SA, Matthews JB et al. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 2005; 128: 1626-41.
3. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
4. Nakamura T, Furukawa Y, Nakagawa H et al. Genome-wide cDNA microarray analysis of gene-expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 2004; 23: 2385-400.
5. Barrett AJ. The cystatins: A new class of peptidase inhibitors. Trends Biochem Sci 1987; 12: 193-6.
6. Henskens YM, Veerman EC, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe Seyler 1996; 377: 71-86.
7. Abrahamson M, Alvarez-Fernandez M, Nathanson CM. Cystatins. Biochem Soc Symp 2003; 70: 179-99.
8. Sotiropoulou G, Anisowicz A, Sager R. Identification, cloning, and characterization of cystatin M, a novel cysteine proteinase inhibitor, down-regulated in breast cancer. J Biol Chem 1997; 272: 903-10.
9. Ni J, Abrahamson M, Zhang M et al. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins. J Biol Chem 1997; 272: 10.853-8.
10. Shridhar R, Zhang J, Song J et al. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Oncogene 2004; 23: 2206-15.
11. Zhang J, Shridhar R, Dai Q et al. Cystatin M. a novel candidate tumor suppressor gene for breast cancer. Cancer Res 2004; 64: 6957-64.
12. Taniuchi K, Nakagawa H, Nakamura T et al. Down-regulation of RAB6KIFL/ KIF20A, a kinesin involved with membrane trafficking of Discs Large Homologue 5, can attenuate growth of pancreatic cancer cell. Cancer Res 2005; 65: 105-12.
13. Guicciardi ME, Deussing J, Miyoshi H et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000; 106: 1127-37.
14. Foghsgaard L, Wissing D, Mauch D et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 2001; 153: 999-1010.
15. Bröker LE, Huisman C, Span SW et al. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agent in non-small cell lung cancer cells. Cancer Res 2004; 64: 27-30.
16. Zeeuwen PL, van Vlijmen-Willems IM, Egami H, Schalkwijk J. Cystatin M/E expression in inflammatory and neoplastic skin disorders. Br J Dermatol 2002; 147: 87-94.
17. Zeeuwen PL, van Vlijmen-Willems IM, Olthuis D et al. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice. Hum Mol Genet 2004; 13: 1069-79.
18. Vigneswaran N, Wu J, Zacharias W. Up-regulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis. Oral Oncol 2003; 39: 559-68.
19. Huang Y, Prasad M, Lemon WJ et al. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 2001; 98: 15044-9.
20. Vigneswaran N, Wu J, Muller S et al. Expression analysis of cystatin C and M in laser-capture microdissected human breast cancer cells. Pathol Res Pract 2005; 200: 753-62.
21. Nishidate T, Katagiri T, Lin ML et al. Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: Identification of genes associated with progression and metastasis. Int J Oncol 2004; 25: 797-819.
22. Fehrenbacher N, Gyrd-Hansen M, Poulsen B et al. Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Cancer Res 2004; 64: 5301-10.
23. Tavera C, Leung-Tack J, Prevot D et al. Cystatin C secretion by rat glomerular mesangial cells: Autocrine loop for in vitro growth-promoting activity. Biochem Biophys Res Commun 1992; 182: 1082-8.
24. Semeni M, Moin K, Sloane B. Imaging proteolysis by living human breast cancer cells. Neoplasia 2000; 2: 496-504.
25. Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell 2006; 126: 855-67.